Insights into Ecto-5’-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study

E-ISSN： 1875-533x|22|15|1776-1792

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.15, 2015-05, pp. : 1776-1792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural and Modeling Studies on ecto-5’-nucleotidase Aiding in Inhibitor Design

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 34-40

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Small Molecule Sulfonic Acids as Ecto-5'-Nucleotidase Inhibitors

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1133-1139

Bentham Science Publishers

Access to resources Recommend Favorite

New Trends in Medicinal Chemistry Approaches to Antiobesity Therapy

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-04 ,pp. : 564-596

Bentham Science Publishers

Access to resources Recommend Favorite

Tyramine produces interstitial adenosine-mediated activation of ecto-5'-nucleotidase in rat heart in vivo

By Obata T. Yamanaka Y.

European Journal of Pharmacology, Vol. 374, Iss. 1, 1999-06 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

The NK-1 Receptor: A New Target in Cancer Therapy

Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. : 909-921

Bentham Science Publishers

Access to resources Recommend Favorite